3-hydroxybenzylhydrazine has been researched along with Idiopathic Parkinson Disease in 1 studies
3-hydroxybenzylhydrazine: decarboxylase inhibitor; RN given refers to parent cpd; structure
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Melamed, E | 1 |
| Hefti, F | 1 |
| Bitton, V | 1 |
| Globus, M | 1 |
1 other study available for 3-hydroxybenzylhydrazine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Suppression of L-dopa-induced circling in rats with nigral lesions by blockade of central dopa-decarboxylase: implications for mechanism of action of L-dopa in parkinsonism.
Topics: Animals; Behavior, Animal; Corpus Striatum; Dopa Decarboxylase; Dopamine; Dopamine Antagonists; Hydr | 1984 |